ENO1 and neoplasm: The stabilization of WTAP further promotes the m6A methylation of enolase 1 (ENO1), influencing the glycolytic activity of breast cancer cells and thereby promoting tumor growth in vivo; this effect is abolished following WTAP silencing [59].